Recent Finacing
Recent Raise
Cambrian Genomics develops DNA‑printing technology and sells synthetic DNA and engineered organisms to pharma, industrial chemical, agricultural, and consumer seed customers while operating an incubator and filing related patents.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor